✦ LIBER ✦

Treatment of carcinoma of the esophagus with 5-fluorouracil and recombinant alfa-2a-interferon

✍ Scribed by Scott Wadler; Stanley Fell; Hilda Haynes; Henry J. Katz; Alla Rozenblit; Ronald Kaleya; Peter H. Wiernik

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 445 KB
Volume: 71
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19930301)71:5<1726::aid-cncr2820710504>3.0.co;2-m

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of multiple myeloma with recom

Treatment of multiple myeloma with recombinant interferon alfa-2a

✍ Ryuzo Ohno; Kiyoji Kimura 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 459 KB 👁 2 views

Phase II clinical trial with 5-fluoroura

Phase II clinical trial with 5-fluorouracil, recombinant interferon-α-2b, and cisplatin for patients with metastatic or regionally advanced carcinoma of the esophagus

✍ Scott Wadler; Hilda Haynes; Jonathan J. Beitler; Xiaoping Hu; Stanley Fell; Marg 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 393 KB 👁 1 views

## Background: Recombinant interferon-alpha (ifn) augments the cytotoxicity of both 5-fluorouracil (5-fu) and cisplatin in vitro. a phase ii study of 5-fu and ifn resulted in response rates of 25-27% in patients with metastatic esophageal carcinoma. ## Methods: A phase ii trial was initiated to d

Treatment of colorectal carcinoma in ado

Treatment of colorectal carcinoma in adolescents and young adults with surgery, 5-fluorouracil/leucovorin/interferon-?2a and radiation therapy

✍ Pratt, Charles B.; Rao, Bhaskar N.; Merchant, Thomas E.; Shah, Amit; Avery, Lora 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB 👁 2 views

A Phase II trial of 5-fluorouracil and r

A Phase II trial of 5-fluorouracil and recombinant alpha-2a-interferon in previously untreated metastatic gastric carcinoma

✍ Richard Pazdur; Jaffer A. Ajani; Rodger Winn; James Bearden; Robert J. Belt; Sus 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 468 KB 👁 2 views

A Phase I1 clinical trial of the combination of 5-fluorouracil (5-FU) and recombinant alpha-2a-interferon (a-2a-IFN) was conducted in 44 patients. Patients had not received chemotherapy previously and had measurable metastatic gastric carcinoma. 5-FU was administered as a continuous infusion at a do

Treatment of advanced medullary thyroid

Treatment of advanced medullary thyroid carcinoma with a combination of recombinant interferon α-2b and octreotide

✍ Giovanni Lupoli; Edvige Cascone; Francesco Arlotta; Giovanni Vitale; Luigi Celen 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 436 KB 👁 2 views

## BACKGROUND. The medical treatment of advanced medullary thyroid carcinoma (MTC) is still questionable. Results of chemotherapy are disappointing with almost no curative responses, few partial responses, and many side-effects. A recent report has suggested the activity of combination recombinant

5-fluorouracil and low-dose recombinant

5-fluorouracil and low-dose recombinant interferon-α-2a in patients with hormone-refractory adenocarcinoma of the prostate

✍ Shinohara, Nobuo; Demura, Takayoshi; Matsumura, Kin-ya; Toyoda, Ken-ichi; Kashiw 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB 👁 1 views

## Background: The effectiveness of a chemotherapy regimen including 5-fluorouracil (5-fu) and recombinant interferon-alpha-2a (rifn-alpha-2a) was evaluated in hormone-refractory prostate cancer patients. ## Methods: Patients received a continuous intravenous infusion of 5-fu at 600 mg/m2/day for